Skopos Labs, Inc. Geron Corp Transaction History

Skopos Labs, Inc.

  • $813 Million
  • Q3 2025

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025
BUY
$1.59 - $3.6 $15,318 - $34,682
9,634 Added 96340.0%
9,644 $15,000
Q4 2024

Jan 15, 2025
BUY
$3.3 - $4.44 $33 - $44
10 New
10 $0

About GERON CORP

GERN Quotes by TradingView
  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $423M
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Skopos Labs, Inc. Portfolio

Follow Skopos Labs, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skopos Labs, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Skopos Labs, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email